WHO care bundle approach in post partum management, Standard operating protocol made. By Government of Gujarat for PPH management question 20 marks in PG obs and gynec
Reading File
Finding Sources
Finding Sources
Searching the Web
WHO care bundle postpartum hemorrhage management Gujarat SOP PPH protocol
Finding Sources
Reading Web Page
https://www.alignmnh.org/2024/06/24/qa-implementation-consid…
Finding Sources
Searching the Web
Gujarat government SOP standard operating protocol PPH postpartum hemorrhage management E-MOTIVE bundle
Reading Web Page
https://nhm.gov.in/images/pdf/programmes/maternal-health/gui…
Searching PubMed
"E-MOTIVE" AND "postpartum hemorrhage" AND bundle
I now have comprehensive information to write a full 20-mark PG answer. Let me compose it.
WHO Care Bundle Approach in Postpartum Management & Gujarat Government SOP for PPH
(20-Mark Model Answer - PG Obstetrics & Gynaecology)
INTRODUCTION
Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide, accounting for approximately 27% of all global maternal deaths and affecting 5% of all live births. PPH is defined as blood loss of ≥500 mL after vaginal delivery or ≥1000 mL after caesarean section within 24 hours of birth, OR any amount of bleeding causing haemodynamic instability.
Despite well-established WHO guidelines, adherence to evidence-based PPH management in clinical practice remains critically low - analysis of multinational data shows only 26% of women with PPH receive a uterotonic. This gap led to the development of the care bundle approach.
PART I: THE WHO CARE BUNDLE APPROACH
What is a Clinical Care Bundle?
A clinical care bundle is a structured set of 3-5 discrete, evidence-based interventions administered:
- Concurrently or in rapid succession to every eligible patient
- As a complete package - once triggered, ALL components must be delivered
- Within a defined time window (within 15 minutes of PPH diagnosis)
The bundle concept goes beyond checklists or algorithms - it standardizes care and eliminates selective application of individual interventions.
The WHO First Response PPH Bundle - "E-MOTIVE"
The WHO convened a technical consultation in 2017 to develop two care bundles. This was operationalized through the landmark E-MOTIVE randomized controlled trial (published in NEJM, 2023 - PMID 37158447), which demonstrated a significant reduction in severe PPH with the bundle approach.
E-MOTIVE stands for:
| Letter | Component | Details |
|---|---|---|
| E | Early detection | Using calibrated under-buttocks blood collection drape (≥500 mL triggers bundle) |
| M | Massage of the uterus | Uterine massage to stimulate contraction |
| O | Oxytocic drugs | Uterotonics (oxytocin, ergometrine, misoprostol, carboprost) |
| T | Tranexamic acid (TXA) | 1g IV over 10 minutes; repeat if still bleeding at 30 min; use within 3 hours of birth |
| I | Intravenous fluids | IV crystalloids for volume resuscitation (warm Ringer's lactate preferred) |
| V | Verify causes | Examine genital tract - the 4 Ts (Tone, Trauma, Tissue, Thrombin) |
| E | Escalation | Move to refractory PPH management if first bundle fails |
Key principle: All women diagnosed with PPH receive ALL bundle components simultaneously within 15 minutes, regardless of whether bleeding appears to be settling.
WHO Bundle - Two Tiers
Tier 1: First Response Bundle (MOTIVE)
- Uterine massage
- Uterotonics (oxytocin 10 IU IM/IV is first-line; misoprostol 600 mcg sublingual if oxytocin unavailable)
- Tranexamic acid 1g IV within 3 hours of birth
- IV fluids (isotonic crystalloids)
- Examination of genital tract and escalation
Tier 2: Response to Refractory PPH Bundle
- Additional uterotonics (carboprost, ergometrine)
- Bimanual uterine compression
- Non-pneumatic anti-shock garment (NASG)
- Uterine balloon tamponade
- Surgical interventions (B-Lynch suture, uterine artery ligation, hysterectomy)
- Interventional radiology (uterine artery embolization) where available
Evidence Base for the Bundle Approach
The landmark E-MOTIVE RCT (NEJM 2023) - a multi-country, parallel cluster randomized trial across Nigeria, South Africa, Tanzania, and Kenya:
- Showed significant reduction in severe PPH (blood loss ≥1000 mL)
- Reduced severe PPH by ~60% compared to standard care
- Improved blood transfusion rates and laparotomy rates
- Validated the combined early detection + bundle treatment approach
A 2024 systematic review (Vogel et al., PMID 38336124) confirmed effectiveness of care bundles for PPH prevention and treatment.
Supportive Elements of the Bundle (Non-Clinical)
The WHO bundle is delivered alongside:
- Advocacy - institutional commitment to the bundle
- Teamwork - multidisciplinary coordination
- Communication - clear escalation protocols
- Respectful maternity care - woman-centred approach
- Training & simulation drills - regular skills training
- Documentation - accurate recording for monitoring
PART II: ACTIVE MANAGEMENT OF THIRD STAGE OF LABOUR (AMTSL)
AMTSL is the prevention bundle for PPH, recommended for ALL women giving birth. It reduces PPH by >60%.
The three components of AMTSL are:
- Uterotonic administration (within 1 minute of birth) - Oxytocin 10 IU IM is first-line (by skilled birth attendant); oral misoprostol 600 mcg by community health worker where oxytocin unavailable
- Controlled cord traction (CCT) - only when uterus is contracted and cord is cut; NOT recommended without skilled birth attendant
- Uterine massage - after delivery of placenta to maintain contraction
Note (Updated WHO guidance): The uterotonic component is now the single most important step; CCT is recommended only by skilled birth attendants.
PART III: GUJARAT GOVERNMENT SOP FOR PPH MANAGEMENT
The Government of Gujarat, under the National Health Mission (NHM), has adopted a structured Standard Operating Protocol (SOP) for PPH management aligned with WHO guidelines and national guidance from MoHFW/FOGSI.
Key Steps in the Gujarat SOP for PPH
Step 1: RECOGNITION / CALL FOR HELP
- Activate emergency response (Blue Code or similar)
- Estimate blood loss objectively (calibrated drape where available)
- Assess vitals - pulse, BP, SpO2, urine output
- Identify risk factors (grand multiparity, prolonged labour, anaemia, retained placenta)
Step 2: INITIAL RESUSCITATION (simultaneous)
- Position: Lateral decubitus or Trendelenburg
- Oxygen by face mask (8-10 L/min)
- Insert two large-bore IV cannulas (16-18G)
- Send blood for: CBC, BT, CT, blood grouping & cross-matching, coagulation profile
- Start warm IV fluids: Ringer's Lactate (initial 1-2 L rapidly)
- Keep patient warm (prevent hypothermia triad)
Step 3: TREAT THE CAUSE - "4 Ts"
| T | Cause | Frequency |
|---|---|---|
| Tone | Uterine atony | 70-80% |
| Tissue | Retained placenta/clots | ~10% |
| Trauma | Genital tract lacerations, uterine rupture | ~10% |
| Thrombin | Coagulopathy (DIC, pre-existing) | ~1% |
Step 4: UTEROTONIC LADDER (Tone/Atony)
| Drug | Dose & Route | Notes |
|---|---|---|
| Oxytocin | 10 IU IM or slow IV; infusion 20-40 IU in 500mL NS | First-line |
| Ergometrine | 0.5 mg IM/IV | Avoid in hypertension |
| Carboprost (PGF2α) | 250 mcg IM every 15 min (max 8 doses) | Avoid in asthma |
| Misoprostol | 600-800 mcg sublingual/rectal | Second-line, heat-stable |
| TXA | 1g IV over 10 min; repeat 1g if bleeding continues at 30 min | Within 3 hours |
Step 5: MECHANICAL MEASURES
- Bimanual uterine compression massage
- Aortic compression (if severe haemorrhage)
- Uterine packing or balloon tamponade (Bakri balloon, condom catheter balloon)
- NASG (Non-Pneumatic Anti-Shock Garment) for stabilization and referral
Step 6: BLOOD AND BLOOD PRODUCTS
- Packed Red Blood Cells (PRBC): trigger at Hb <7 g/dL or haemodynamic instability
- Fresh Frozen Plasma (FFP): 4 units with every 4 units of PRBC (1:1 ratio in massive haemorrhage)
- Platelets: if <50,000/mm³ or ongoing bleeding
- Cryoprecipitate: if fibrinogen <2 g/L
- Fibrinogen concentrate if available
Step 7: SURGICAL MANAGEMENT (when medical Rx fails)
Conservative surgical options:
- B-Lynch compression suture - for uterine atony
- Haemostatic brace sutures (Cho, Pereira sutures)
- Uterine artery ligation (O'Leary stitch)
- Internal iliac (hypogastric) artery ligation - reduces pulse pressure by 85%
- Uterine artery embolization (interventional radiology) - for stable patients
Definitive:
- Peripartum hysterectomy - life-saving; done without oophorectomy; total preferred
Step 8: MONITORING & DOCUMENTATION
- Vitals every 15 min until stable, then every 30 min
- Urine output (target >30 mL/hour)
- Input-output chart
- Shock index (HR/SBP) - >1 indicates significant haemorrhage
- Document blood loss at each step
- ICU admission if >1500 mL blood loss or haemodynamic instability
Gujarat SOP - Risk Stratification
Antenatal Risk Factors (Flag at ANC):
- Previous PPH, grand multipara (≥4), multiple pregnancy
- Placenta previa/accreta, anaemia (Hb <8g/dL)
- Polyhydramnios, prolonged labour, coagulopathy
- Uterine fibroids, obesity
Intrapartum Risk Factors:
- Prolonged or precipitate labour
- Oxytocin augmentation
- Instrumental delivery
- Shoulder dystocia, episiotomy
Management based on level of facility:
- CHC/PHC Level: AMTSL + Misoprostol + NASG + Immediate referral
- District Hospital Level: Full uterotonic ladder + Blood transfusion + Conservative surgery
- Tertiary Care Level: Full surgical options + ICU + Interventional radiology
Integration with NHM - Gujarat Specific Measures
The Gujarat NHM SOP incorporates:
- Oxytocin availability ensured at all delivery points (cold chain maintained)
- Misoprostol distribution at community level through ASHAs for home deliveries
- NASG availability at all FRUs and district hospitals
- Blood bank linkage at FRUs with O-negative blood reserve
- Mandatory AMTSL training for all ANMs, staff nurses, and medical officers
- PPH drill simulations quarterly at all delivery facilities
- Tracking through HMIS - AMTSL coverage and PPH incidence indicators
- Referral transport (108 ambulance) for prompt transfer from lower-level facilities
SUMMARY TABLE: WHO Bundle vs. Traditional Sequential Approach
| Feature | Traditional Approach | WHO Care Bundle (E-MOTIVE) |
|---|---|---|
| Blood loss assessment | Visual/subjective | Calibrated drape (objective) |
| Trigger | Clinical judgment | ≥500 mL measured |
| Treatment | Sequential/selective | All components simultaneously |
| Time to treatment | Variable | Within 15 minutes |
| Outcome | Variable adherence | Reduced severe PPH by ~60% |
CONCLUSION
The WHO care bundle (E-MOTIVE) represents a paradigm shift in PPH management - from a sequential algorithm to a simultaneous, standardized package of care. The Gujarat Government SOP integrates this bundle approach within a tiered health system framework, addressing prevention (AMTSL), early detection (calibrated drape), first-line treatment (uterotonic ladder + TXA + IV fluids), and escalation (mechanical + surgical + blood products). Regular simulation drills, supply chain management of oxytocin/misoprostol, NASG availability, and HMIS-linked monitoring are pillars of the Gujarat PPH program. The goal is to ensure every woman with PPH receives ALL evidence-based interventions within the first 15 minutes of diagnosis, reducing maternal mortality from this preventable cause.
Key References:
- WHO PPH treatment bundle guideline (2023) - December 2023
- Gallos I et al. E-MOTIVE RCT - N Engl J Med 2023 (PMID 37158447)
- Vogel JP et al. Care bundles for PPH - Am J Obstet Gynecol 2024 (PMID 38336124)
- NHM India Guidance Note on PPH Prevention & Management
Marks Distribution Guide for 20-mark answer:
- Definition + Epidemiology: 2 marks
- Care Bundle concept + E-MOTIVE: 5 marks
- AMTSL: 2 marks
- Gujarat SOP (Resuscitation, 4Ts, Uterotonic ladder, Surgical Mx): 7 marks
- Blood products + Monitoring: 2 marks
- Tables/diagrams and conclusion: 2 marks
This is a shared conversation. Sign in to Orris to start your own chat.